Outcomes With Eculizumab and Responses to Withdrawal for Atypical Hemolytic Uremic Syndrome
Among patients who underwent eculizumab withdrawal, 76.9% remained in remission during the course of the study.
All articles by Vicki Moore, PhD
Whole Blood Ristocetin-Induced Platelet Aggregometry for Determining von Willebrand Disease Severity
Assay values were not strongly correlated with von Willebrand factor ristocetin cofactor or antigen activity.
Prolonged-Release Anagrelide May Be Safe and Efficacious Against Thrombocythemia
Prolonged-release administration of anagrelide resulted in a noninferior decrease in mean platelet levels compared with immediate-release administration.
Discriminating Coagulation Patterns in Cyanotic, Noncyanotic Congenital Heart Disease
Patients with cyanotic congenital heart diseases were found to have higher levels of hematocrit, hemoglobin, and reticulocytes.
Relapse Risk in Pediatric Acute Myeloid Leukemia With Granulocyte Colony-Stimulating Factor
Relapse risk increased with cumulative granulocyte colony-stimulating factor dosage but appeared to level out at approximately 75 mg/kg to 100 mg/kg.
Long-Term Outcomes of Fostamatinib for Immune Thrombocytopenia
Researchers reviewed outcomes from several phase 3 trials assessing the feasibility of fostamatinib for immune thrombocytopenia.
Features of Autoimmune Hemolytic Anemia With Immune Checkpoint Inhibitor Treatment
Immune checkpoint inhibitor (ICI) therapy may lead to autoimmune hemolytic anemia (AIHA), but diagnosis of AIHA may not necessitate ICI discontinuation.
Antibiotic Discontinuation in Neutropenic Patients With Acute Myeloid Leukemia
Discontinuing antibacterial therapy in neutropenic patients with acute myeloid leukemia did not lead to excessive mortality or severe infections.
Consensus Panel on Maintenance Therapies Following Autologous Hematopoietic Cell Transplantation in Lymphoma
An expert panel reviewed current literature surrounding lymphoma treatment to identify and address any gaps in knowledge.
Optimal Platelet Transfusion Threshold Unknown in Patients Undergoing Lumbar or Epidural Procedures
Unnecessarily high platelet count thresholds may expose patients undergoing lumbar or epidural procedures to excessive transfusion-related risks.
Next post in Bleeding Disorders
